← Leaderboards
Vinod D Labhasetwar
Cleveland Clinic Lerner Com-Cwru
$14,028,234
Attributed
$14,622,609
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,622,609 · 13
By mechanism
R01$13,216,455 · 8
R21$900,041 · 3
R41$399,987 · 1
R29$106,126 · 1
Top collaborators
- Minzhong Yu3 shared
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleBaseIntravenous AdministrationDoseEncapsulatedCellsEffective TherapyMediatingResponseAcuteOxidative StressEventDesignPreventPublic Health RelevanceTissuesFda ApprovedUptakeDrug Delivery SystemsIntravenousPharmaceutical PreparationsReactive Oxygen SpeciesNanoCatalase
Grant awards (47)
tPA nanoconjugate for stroke therapy$401,062
R01 · FY2024 · NS · contact PI
tPA nanoconjugate for stroke therapy$413,466
R01 · FY2022 · NS · contact PI
tPA nanoconjugate for stroke therapy$413,466
R01 · FY2021 · NS · contact PI
Neupronâ¢: A Neuroprotective Agent for Treating Acute Spinal Cord Injury$399,987
R41 · FY2021 · NS · contact PI
Nanoparticle-mediated treatment for bone metastasis$268,394
R01 · FY2021 · CA · contact PI
tPA nanoconjugate for stroke therapy$413,466
R01 · FY2020 · NS · contact PI
Nanoparticle-mediated treatment for bone metastasis$44,168
R01 · FY2020 · CA · contact PI
Neuronal Protective Nanoparticles for Treating Acute SCI$446,105
R01 · FY2019 · NS · contact PI
tPA nanoconjugate for stroke therapy$427,612
R01 · FY2019 · NS · contact PI
Nanoparticle-mediated treatment for bone metastasis$303,185
R01 · FY2019 · CA · contact PI
Neuronal Protective Nanoparticles for Treating Acute SCI$446,105
R01 · FY2018 · NS · contact PI
Nanoparticle-based therapy for photoreceptor degeneration$396,250
R01 · FY2018 · EY · contact PI
Nanoparticle-mediated treatment for bone metastasis$312,562
R01 · FY2018 · CA · contact PI
Neuronal Protective Nanoparticles for Treating Acute SCI$446,105
R01 · FY2017 · NS · contact PI
Nanoparticle-based therapy for photoreceptor degeneration$396,250
R01 · FY2017 · EY · contact PI
Nanoparticle-mediated treatment for bone metastasis$312,562
R01 · FY2017 · CA · contact PI
Neuronal Protective Nanoparticles for Treating Acute SCI$446,105
R01 · FY2016 · NS · contact PI
Nanoparticle-based therapy for photoreceptor degeneration$396,250
R01 · FY2016 · EY · contact PI
Nanoparticle-mediated treatment for bone metastasis$312,562
R01 · FY2016 · CA · contact PI
Neuronal Protective Nanoparticles for Treating Acute SCI$462,605
R01 · FY2015 · NS · contact PI
Stroke Therapy$458,673
R01 · FY2014 · NS · contact PI
Drug Resistance In Cancer Therapy$384,382
R01 · FY2014 · CA · contact PI
Stroke Therapy$446,911
R01 · FY2013 · NS · contact PI
Drug Resistance In Cancer Therapy$372,492
R01 · FY2013 · CA · contact PI
Stroke Therapy$462,999
R01 · FY2012 · NS · contact PI
Drug Resistance In Cancer Therapy$396,268
R01 · FY2012 · CA · contact PI
Stroke Therapy$459,061
R01 · FY2011 · NS · contact PI
Drug Resistance In Cancer Therapy$397,152
R01 · FY2011 · CA · contact PI
Stroke Therapy$478,636
R01 · FY2010 · NS · contact PI
Drug Resistance In Cancer Therapy$438,437
R01 · FY2010 · CA · contact PI
Nuclear-targeted nanoparticles for gene delivery$258,417
R01 · FY2008 · EB · contact PI
Biomagnetic Nanoparticles for Drug Delivery and Imaging$258,152
R01 · FY2008 · EB · contact PI
Biomagnetic Nanoparticles for Drug Delivery and Imaging$275,331
R01 · FY2007 · EB · contact PI
Nuclear-targeted nanoparticles for gene delivery$263,690
R01 · FY2007 · EB · contact PI
Drug Resistance in Cancer Therapy$142,519
R21 · FY2007 · CA · contact PI
Nuclear-targeted nanoparticles for gene delivery$271,565
R01 · FY2006 · EB · contact PI
Biomagnetic Nanoparticles for Drug Delivery and Imaging$248,909
R01 · FY2006 · EB · contact PI
Drug Resistance in Cancer Therapy$139,650
R21 · FY2006 · CA · contact PI
Nuclear-targeted nanoparticles for gene delivery$287,100
R01 · FY2005 · EB
TAT-Peptide conjugated nanoparticles for CNS Delivery$228,791
R21 · FY2005 · MH
TAT-Peptide conjugated nanoparticles for CNS Delivery$220,500
R21 · FY2004 · MH
TAT-Peptide conjugated nanoparticles for CNS Delivery$8,291
R21 · FY2004 · MH
Intrarticular SLPI Therapy for Rheumatoid Arthritis$73,500
R21 · FY2002 · AR
Intrarticular SLPI Therapy for Rheumatoid Arthritis$8,702
R21 · FY2002 · AR
Intrarticular SLPI Therapy for Rheumatoid Arthritis$4,359
R21 · FY2002 · AR
Intrarticular SLPI Therapy for Rheumatoid Arthritis$73,729
R21 · FY2001 · AR
BIODEGRADABLE RELEASE NANOPARTICLES FOR RESTENOSIS$106,126
R29 · FY2000 · HL